Correlation Between Vyne Therapeutics and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Vyne Therapeutics and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and Kalvista Pharmaceuticals.
Diversification Opportunities for Vyne Therapeutics and Kalvista Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Vyne and Kalvista is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vyne Therapeutics and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Vyne Therapeutics is expected to generate 1.22 times more return on investment than Kalvista Pharmaceuticals. However, Vyne Therapeutics is 1.22 times more volatile than Kalvista Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Kalvista Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 179.00 in Vyne Therapeutics on November 2, 2024 and sell it today you would earn a total of 57.00 from holding Vyne Therapeutics or generate 31.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vyne Therapeutics vs. Kalvista Pharmaceuticals
Performance |
| Timeline |
| Vyne Therapeutics |
| Kalvista Pharmaceuticals |
Vyne Therapeutics and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vyne Therapeutics and Kalvista Pharmaceuticals
The main advantage of trading using opposite Vyne Therapeutics and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.| Vyne Therapeutics vs. Akari Therapeutics PLC | Vyne Therapeutics vs. Salarius Pharmaceuticals | Vyne Therapeutics vs. Histogen | Vyne Therapeutics vs. SAB Biotherapeutics |
| Kalvista Pharmaceuticals vs. Surrozen | Kalvista Pharmaceuticals vs. Armata Pharmaceuticals | Kalvista Pharmaceuticals vs. Pasithea Therapeutics Corp | Kalvista Pharmaceuticals vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |